J Korean Neurol Assoc.  2007 Aug;25(3):318-323.

Neuroimaging of Hemichorea-Hemiballism

Affiliations
  • 1Department of Neurology, Kyung Hee University College of Medicine, Seoul, Korea. ricash@hanmail.net
  • 2Department of Nuclear Medicine, Kyung Hee University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND: Hemichorea-Hemiballism (HCHB) can be caused by various diseases such as cerebrovascular disease, hyperglycemia, tumor, and inflammatory diseases. However, there are a few case studies using functional imaging such as single photon emission computed tomography (SPECT).
METHODS
In this study, we included patients with HCHB. The patients with hyperglycemia over 250 mg/dl or high signal intensity on T1 weighted imaging were excluded. Clinical and neuroimaging characteristics of the patients were obtained and analyzed.
RESULTS
We included 20 patients (M:F=12:8, mean age=67.1+/-15.3). Sixteen patients were presented with hemiballism and four with hemichorea. Six patients had no structural lesions causing HCHB. Subthalamic nucleus was the causative lesion in 6 patients. Other lesions associated with HCHB were basal ganglia, thalamus, and cortices. In a patient without structural lesion, anti-double stranded DNA antibody was detected. Brain SPECT showed not only perfusion abnormalities in the cases without structural lesions but also additional abnormalities in those with definite lesions.
CONCLUSIONS
Various mechanisms were related to the development of HCHB. Functional imaging such as SPECT and immunological work-up is needed to investigate the underlying pathomechanism of HCHB.

Keyword

Hemichorea; Hemiballism; Subthalamic nucleus; SPECT

MeSH Terms

Basal Ganglia
Brain
DNA
Dyskinesias
Humans
Hyperglycemia
Neuroimaging*
Perfusion
Subthalamic Nucleus
Thalamus
Tomography, Emission-Computed, Single-Photon
DNA
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr